Surgery for Li Fraumeni Syndrome: Pushing the Limits of Surgical Oncology. (February 2015)

• Record Type: Journal Article
• Authors: Langan, Russell C.; Lagisetty, Kiran H.; Atay, Scott; Pandalai, Prakash; Stojadinovic, Alexander; Rudloff, Udo; Avital, Itzhak
• Is Part Of: American journal of clinical oncology. Volume 38:Number 1(2015)
• Publication Date: 2015-02
• Subjects: Li Fraumeni syndrome -- metastasectomy -- simultaneous pancreaticoduodenectomy and hepatectomy; Cancer -- Treatment -- Periodicals; Oncology -- Periodicals; Tumors -- Periodicals; 616.994005
• DOI: 10.1097/COC.0b013e3182880bc5
• Languages: English
• ISSNs: 0277-3732

Abstract

Abstract : Objectives: Li Fraumeni syndrome is an autosomal dominant cancer syndrome due to a germline mutation in the p53 tumor suppressor gene. It results in multiple primary neoplasms in children and adults. A common question when faced with a Li Fraumeni patient who develops multiple primary cancers and/or recurrences is what is the proper treatment? Data suggests that ionizing radiation exposure increases the incidence of second malignancies in the Li Fraumeni population. Therefore, how much surgery can a cancer patient tolerate and still derive benefit from it? Methods: We describe a representative case of a 54-year-old female with Li Fraumeni syndrome with an enlarging adrenocortical hepatic metastasis, a new primary ampullary cancer, and an extensive surgical history. Results: We performed a simultaneous pancreaticoduodenectomy and repeat partial hepatectomy. Conclusions: We propose that surgery is underutilized in metastatic solid organ familial cancers in general, and argue that an aggressive surgical approach should be considered in a multidisciplinary manner for patients with Li Fraumeni syndrome and recurrent tumors. However, because of the rarity of this familial cancer there is a paucity of evidence to support this approach, therefore a review of the literature is presented.